uppP operates in the undecaprenyl phosphate biosynthesis pathway:
Reaction: Hydrolyzes UPP (C55-PP) to UP (C55-P), releasing inorganic pyrophosphate .
Role in Cell Wall Synthesis: UP transports lipid-linked peptidoglycan precursors across the cytoplasmic membrane .
Kinetics: Mutagenesis studies on homologous enzymes highlight the importance of residues like Tyr-148 and Trp-224 for catalytic efficiency (e.g., 10–1,600-fold reductions in k<sub>cat</sub>/K<sub>m</sub> upon mutation) .
Substrate Binding: Conserved aromatic residues facilitate interactions with isopentenyl diphosphate (IPP) and farnesyl diphosphate (FPP) .
Inhibition: Small-molecule inhibitors (e.g., UK-106051) disrupt UPP synthesis by competitively binding to the FPP/UP site, demonstrating potential as antibacterial agents .
Heterologous Expression: K. rhizophila DC2201 is engineered for biocatalysis using shuttle vectors (e.g., pKITE301), enabling high-yield production of recombinant enzymes like uppP .
Industrial Relevance: Solvent-tolerant Kocuria strains serve as chassis for producing enantiopure compounds (e.g., (S)-styrene oxide) in biphasic reaction systems .
KEGG: krh:KRH_13930
STRING: 378753.KRH_13930
Kocuria rhizophila uppP (EC 3.6.1.27) functions as an integral membrane protein that catalyzes the dephosphorylation of undecaprenyl pyrophosphate to undecaprenyl phosphate, a critical carrier lipid in bacterial cell wall synthesis. This enzymatic activity is essential for recycling the lipid carrier and maintaining bacterial cell wall integrity. The enzyme contains two consensus regions with (E/Q)XXXE plus PXSRSXXT motifs that are oriented toward the periplasmic site, indicating its biological function occurs on the outer side of the plasma membrane . The dephosphorylation reaction is critical for bacterial survival as it regenerates the lipid carrier required for peptidoglycan synthesis.
While both enzymes participate in the same metabolic pathway, they catalyze distinct reactions:
| Feature | Undecaprenyl-diphosphatase (uppP) | Undecaprenyl pyrophosphate synthase (UPPs) |
|---|---|---|
| Catalytic function | Dephosphorylates undecaprenyl pyrophosphate | Catalyzes condensation of IPP onto FPP to produce UPP |
| Reaction type | Hydrolysis | Consecutive condensations |
| Cellular location | Integral membrane protein | Soluble/peripheral membrane protein |
| Alternative names | Bacitracin resistance protein | Di-trans,poly-cis-decaprenylcistransferase |
| EC number | 3.6.1.27 | 2.5.1.31 |
| Key structural motifs | (E/Q)XXXE plus PXSRSXXT | Aspartate-rich motifs |
UPPs catalyzes the consecutive condensations of isopentenyl pyrophosphate (IPP) groups onto trans-farnesyl pyrophosphate (FPP) to produce the C55 isoprenoid undecaprenyl pyrophosphate (UPP) , while uppP subsequently dephosphorylates this product to enable recycling in the bacterial cell wall synthesis pathway .
For recombinant K. rhizophila uppP, optimal storage conditions are:
Short-term storage (up to one week): 4°C in working aliquots
Long-term storage: -20°C or -80°C for extended preservation
Storage buffer: Tris-based buffer with 50% glycerol, optimized for protein stability
Handling: Repeated freezing and thawing is not recommended as it significantly reduces enzyme activity
When preparing aliquots, it's advisable to use volumes appropriate for single experiments to minimize freeze-thaw cycles. The presence of 50% glycerol in the storage buffer helps maintain enzyme stability during freezing by preventing ice crystal formation that can disrupt protein structure.
Site-directed mutagenesis studies have identified several key residues essential for uppP activity:
Conserved histidine residue (His-30): Located near the aqueous interface and oriented toward the periplasmic site. The H30A mutant exhibits severely impaired enzyme activity, suggesting its critical role in catalysis .
Arginine-174: Forms hydrogen bonds with the hydroxyl group of the pyrophosphate moiety. The R174A mutant is completely inactive, demonstrating this residue's essential role in substrate binding and/or catalysis .
Two consensus regions: The (E/Q)XXXE motif and PXSRSXXT motif together form the active site of uppP. The proximity of these regions to the aqueous interface suggests they create a pocket accessible to the pyrophosphate moiety of the substrate .
Transmembrane topology: The proper orientation of the enzyme within the membrane is critical for accessing its substrate. The active site appears to be positioned to interact with the pyrophosphate group while the undecaprenyl chain remains embedded in the membrane .
Mutation of these key residues provides valuable insights into the catalytic mechanism and could inform the design of specific inhibitors targeting uppP activity.
Recombinant K. rhizophila uppP activity is influenced by several environmental factors:
| Factor | Optimal Range | Effect on Activity | Experimental Consideration |
|---|---|---|---|
| pH | 5.7-7.5 | Maximum activity at neutral pH; significant decrease outside this range | Buffer selection is critical; phosphate or Tris buffers at physiological pH are recommended |
| Temperature | 10-40°C | Activity increases with temperature up to ~37°C, then decreases | Assays typically conducted at 30-37°C; K. rhizophila is mesophilic |
| Salt concentration | Tolerates up to 15% (w/v) NaCl | High salt can enhance stability but may affect kinetics | Salt concentration should be optimized for specific assay conditions |
| Detergent | Depends on detergent type | Necessary for solubilization but can inhibit at high concentrations | Mild detergents like DDM at concentrations just above CMC are recommended |
The integral membrane nature of uppP necessitates careful consideration of these factors in experimental design. For in vitro activity assays, the choice of detergent is particularly critical as it must maintain the protein in a soluble, correctly folded state while allowing substrate access to the active site .
Studying inhibition mechanisms of uppP requires multifaceted approaches:
Biochemical assays: Measure dephosphorylation activity using synthetic substrates in the presence of potential inhibitors. Kinetic parameters (IC50, Ki) can be determined through Michaelis-Menten analysis.
Biophysical methods:
Surface Plasmon Resonance (SPR) to measure binding kinetics (kon and koff rates)
Isothermal Titration Calorimetry (ITC) to determine thermodynamic parameters
Differential Scanning Fluorimetry (DSF) to assess thermal stability changes upon inhibitor binding
Structural studies: Co-crystallization with inhibitors or substrate analogs can reveal binding modes. For membrane proteins like uppP, this typically requires:
Detergent solubilization and purification
Lipidic cubic phase crystallization methods
Cryo-electron microscopy as an alternative approach
Computational approaches:
Molecular docking to predict inhibitor binding poses
Molecular dynamics simulations to understand conformational changes
Virtual screening to identify novel inhibitor candidates
Understanding allosteric inhibition mechanisms, similar to those observed for UPPs with compounds like UK-106051, could provide valuable insights. For UPPs, the presence of FPP alters inhibitor binding kinetics, resulting in a 25-fold increase in binding affinity (KD 6.6 ± 0.7 × 10−8 M with FPP vs. KD 1.7 ± 0.3 × 10−6 M without) . Similar cooperative binding mechanisms may exist for uppP inhibitors.
Given the membrane-bound nature of uppP, selecting an appropriate expression system is critical:
E. coli-based expression systems:
pET vector systems: High expression levels but may lead to inclusion body formation
C41/C43 strains: Engineered for membrane protein expression with reduced toxicity
Fusion tags: bacteriorhodopsin tag has been successfully used for expression of similar membrane proteins
Induction conditions: Lower temperatures (16-25°C) and reduced inducer concentrations often improve soluble expression
Cell-free expression systems:
Allow direct incorporation into liposomes or nanodiscs
Eliminate toxicity issues associated with membrane protein overexpression
Enable controlled addition of detergents or lipids
Yeast expression systems:
Pichia pastoris provides eukaryotic machinery with high expression levels
Natural membrane insertion machinery may improve folding
For uppP specifically, a solution expression system has been successfully employed for the related undecaprenyl diphosphate synthase in E. coli, achieving near homogeneity in purification . The addition of a bacteriorhodopsin tag at the N-terminus has improved expression of similar membrane proteins .
Purification of membrane proteins like uppP requires specialized approaches:
Membrane extraction and solubilization:
Isolate membrane fraction through differential centrifugation
Solubilize using mild detergents (DDM, LMNG, or CHAPS)
Optimize detergent:protein ratio to prevent aggregation
Chromatography sequence:
Immobilized Metal Affinity Chromatography (IMAC): Initial capture using His-tag
Ion Exchange Chromatography: Further purification based on charge differences
Size Exclusion Chromatography: Final polishing step and buffer exchange
Quality assessment:
SDS-PAGE and Western blotting for purity and identity confirmation
Mass spectrometry for accurate molecular weight determination
Dynamic Light Scattering to verify monodispersity
Circular Dichroism to assess secondary structure
For related enzymes, a multi-step chromatography approach has been effective, including TSK-DEAE, ceramic hydroxyapatite, TSK-ether, Superdex 200, and heparin-Actigel chromatography . Throughout purification, maintaining an appropriate detergent concentration above the critical micelle concentration is essential to prevent protein aggregation.
Several complementary methods can be used to assess uppP activity:
When designing activity assays, researchers should consider:
Buffer composition (pH, ionic strength)
Detergent type and concentration
Divalent cation requirements (Mg2+, Mn2+)
Temperature and incubation time
Substrate concentration and solubility
Investigating structure-function relationships in membrane proteins like uppP requires integrated approaches:
Computational structure prediction:
Site-directed mutagenesis:
Targeting conserved residues identified through sequence alignment
Systematic mutation of predicted active site residues
Creation of chimeric proteins to identify functional domains
Biophysical characterization:
Thermostability analysis through differential scanning calorimetry
Conformational changes monitored by intrinsic fluorescence
Binding studies using isothermal titration calorimetry
Structural biology techniques:
X-ray crystallography (challenging for membrane proteins)
Cryo-electron microscopy for high-resolution structure determination
Hydrogen-deuterium exchange mass spectrometry to probe solvent accessibility
Functional correlation:
Kinetic analysis of mutants to determine effects on catalytic parameters
Inhibitor binding studies to identify interaction sites
In vivo complementation studies to assess functional relevance
For uppP specifically, a two-dimensional structure prediction has shown that consensus regions containing (E/Q)XXXE plus PXSRSXXT motifs and a histidine residue are localized near the aqueous interface and oriented toward the periplasmic site . This provides a starting point for further investigation of the active site architecture and catalytic mechanism.
As an essential enzyme in bacterial cell wall synthesis, uppP presents a promising antimicrobial target:
Rational inhibitor design:
Structure-based design targeting the active site
Allosteric inhibitors that disrupt enzyme dynamics
Peptidomimetics based on known inhibitors like bacitracin
Screening approaches:
High-throughput screening of chemical libraries
Fragment-based drug discovery
Natural product screening focusing on compounds with known cell wall effects
Combination therapy strategies:
Synergy with existing cell wall-targeting antibiotics
Dual inhibition of uppP and related enzymes like UPPs
Membrane permeabilizers to enhance inhibitor access
Species selectivity considerations:
Exploiting structural differences between bacterial species
Targeting K. rhizophila-specific features for selective applications
Broad-spectrum vs. narrow-spectrum inhibitor development
UPPs inhibition has demonstrated a cidal mechanism with more than three log units of reduction in viable bacterial counts observed at 24 hours , suggesting that targeting this pathway is a viable antimicrobial strategy. Similar effects might be expected for uppP inhibition.
Understanding uppP can provide insights into bacterial resistance mechanisms:
Bacitracin resistance: uppP is alternatively named "Bacitracin resistance protein" as it plays a role in resistance to this antibiotic . Increased expression or mutations in uppP can confer resistance by:
Increasing the rate of undecaprenyl pyrophosphate recycling
Altering the binding site for bacitracin
Changing the membrane localization of the enzyme
Cross-resistance patterns: Modifications in uppP may affect susceptibility to other cell wall-targeting antibiotics through:
Altered peptidoglycan synthesis rates
Changes in cell wall composition
Modified membrane permeability
Horizontal gene transfer: Acquisition of variant uppP genes might contribute to resistance spread among bacterial populations.
Compensatory mutations: Bacteria might develop alternative pathways or regulatory mechanisms to compensate for reduced uppP function under selective pressure.